1.
Salazar Gómez L, Grisales Negrete JP. Molecular and clinical evidence of the cardiovascular benefit of SGLT2 inhibitors: State of the art. Med UPB [Internet]. 2022 Aug. 8 [cited 2026 Jun. 14];41(2):145-56. Available from: https://revistas.upb.edu.co/index.php/medicina/article/view/7884